Genetic testing for familial melanoma.

Abstract excerpt

While the average lifetime risk of melanoma worldwide is approximately 3%, those with inherited high-penetrance mutations face an increased lifetime risk of 52-84%. In countries of low melanoma incidence, such as in Southern Europe, familial melanoma genetic testing may be warranted when there are two first degree relatives with a melanoma diagnosis. Testing criteria for high incidence countries such as USA, or...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cyclin-Dependent Kinase Inhibitor p16
• Share to Dysplastic Nevus Syndrome